Advancing Precision Medicine: Abartys Health Publishes in Scientific Reports

Abartys Health’s latest research, published in Scientific Reports, introduces a deep learning model for indirect reference interval estimation, focusing on the ovarian cancer biomarker CA-125. This innovative approach challenges standard reference limits, highlighting the importance of data-driven insights in precision medicine.
Published on
November 11, 2024

Innovating Reference Interval Estimation with AI

In the article, “Indirect reference interval estimation using a convolutional neural network with application to cancer antigen 125 (CA-125),” Abartys Health presents a groundbreaking deep learning method. This model improves the accuracy of reference interval estimation, specifically for CA-125, a biomarker crucial for detecting ovarian cancer.

The study applied this model to a large dataset of CA-125 results from Puerto Rican women, uncovering significant age-dependent variations in CA-125 levels. These findings suggest the need to revise standard reference limits, enhancing early detection and personalized treatment strategies.

The Power of Big Data and Advanced Analytics

The research underscores Abartys Health’s commitment to leveraging big data processing and advanced analytics on AWS cloud infrastructure. By combining clinical expertise with cutting-edge AI, Abartys Health is driving advancements in precision medicine and improving patient outcomes.

“This study exemplifies how deep learning can transform clinical data into actionable insights, paving the way for more accurate and personalized healthcare.”

– Abartys Health Research Team

Why This Matters

The findings emphasize the potential of AI and machine learning to refine diagnostic tools, optimize treatment plans, and improve healthcare delivery. This aligns with Abartys Health’s mission to enhance healthcare data interoperability and enable data-driven decision-making.

Here the link to the research

Latest News

Other News

Interviews, tips, guides, industry best practices, and news.

Abartys Health Achieves AWS Healthcare Service Competency

Abartys Health has been recognized for its expertise in delivering AWS-powered healthcare solutions, improving patient outcomes, and driving innovation through scalable, secure, and compliant platforms.
Read news

Los retos de vivir con diabetes den Puerto Rico

Abartys Health leverages advanced data analytics to improve public policy and interventions for diabetes care in Puerto Rico. In the central region, diabetes prevalence has risen from 21.6% to 26.8% between 2019 and 2022. This National Diabetes Month, Abartys Health celebrates its collaborative study making front-page news, showcasing its commitment to transforming patient lives through actionable data.
Read news

Diabetes Prevalence in Puerto Rico Potentially Much Higher than Official Estimate

A new analysis by Abartys Health and the Puerto Rico Diabetes Association reveals diabetes prevalence in Puerto Rico is significantly higher than official estimates, with nearly 50% of the population impacted by diabetes or prediabetes. Leveraging real-world clinical data, the study underscores the importance of advanced analytics and prevention strategies to address this growing health crisis.
Read news